Fairmount Funds Management LLC - Director at Dianthus Therapeutics, Inc. /DE/

Insider Transactions and Holdings

Entity Type
Company
Role
Director
Issuer Symbol
DNTH on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Fairmount Funds Management LLC since 06 Feb 2025

Holdings reported by Fairmount Funds Management LLC for Dianthus Therapeutics, Inc. /DE/

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,700,691 $32,408,292 $12.00 27 Sep 2024 By Fairmount Healthcare Fund II L.P.
Pre-Funded Warrants (Right to Buy) 832,333 $9,987,164 $12.00 22 Jan 2024 Indirect Common Stock
Common Stock 0 $0 $12.00 27 Sep 2024 By Fairmount SPV III, LLC
Stock Option (Right to Buy) 11,000 23 May 2024 Indirect Common Stock

Transactions reported by Fairmount Funds Management LLC for Dianthus Therapeutics, Inc. /DE/

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.